Page last updated: 2024-08-25

clarithromycin and Brain Vascular Disorders

clarithromycin has been researched along with Brain Vascular Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ärnlöv, J; Bring, C; Carlsson, AC; Gluud, C; Hilden, J; Jakobsen, JC; Jensen, GB; Kastrup, J; Kjøller, E; Kolmos, HJ; Larsson, A; Sajadieh, A; Winkel, P; Wuopio, J	1

Trials

1 trial(s) available for clarithromycin and Brain Vascular Disorders

Article	Year
Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study. Atherosclerosis, 2018, Volume: 278 Topics: Aged; Angina, Unstable; Atherosclerosis; Cardiovascular Diseases; Cathepsin B; Cathepsins; Cerebrovascular Disorders; Clarithromycin; Coronary Disease; Denmark; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Lysosomes; Male; Middle Aged; Mortality; Myocardial Infarction; Peripheral Vascular Diseases; Proportional Hazards Models; Registries; Risk Factors; Treatment Outcome	2018

Article

Year

Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study.

Atherosclerosis, 2018, Volume: 278

Topics: Aged; Angina, Unstable; Atherosclerosis; Cardiovascular Diseases; Cathepsin B; Cathepsins; Cerebrovascular Disorders; Clarithromycin; Coronary Disease; Denmark; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Lysosomes; Male; Middle Aged; Mortality; Myocardial Infarction; Peripheral Vascular Diseases; Proportional Hazards Models; Registries; Risk Factors; Treatment Outcome

2018